At the time of writing, LifeStance Health Group Inc [LFST] stock is trading at $6.75, up 4.17%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The LFST shares have gain 5.47% over the last week, with a monthly amount glided 4.98%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
LifeStance Health Group Inc [NASDAQ: LFST] stock has seen the most recent analyst activity on December 09, 2025, when Barclays initiated its Overweight rating and assigned the stock a price target of $8. Previously, BMO Capital Markets started tracking the stock with Outperform rating on November 13, 2025, and set its price target to $8. On July 25, 2025, BTIG Research initiated with a Buy rating and assigned a price target of $8 on the stock. UBS upgraded its rating to a Buy but stick to its price target of $8.50 on May 27, 2025. KeyBanc Capital Markets initiated its recommendation with an Overweight and recommended $9 as its price target on April 08, 2025. Canaccord Genuity started tracking with a Buy rating for this stock on April 03, 2025, and assigned it a price target of $8. In a note dated December 16, 2024, Goldman upgraded a Buy rating on this stock but restated the target price of $10.
For the past year, the stock price of LifeStance Health Group Inc fluctuated between $3.74 and $8.30. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. LifeStance Health Group Inc [NASDAQ: LFST] shares were valued at $6.75 at the most recent close of the market. An investor can expect a potential return of 18.52% based on the average LFST price forecast.
Analyzing the LFST fundamentals
According to LifeStance Health Group Inc [NASDAQ:LFST], the company’s sales were 1.37B for trailing twelve months, which represents an 16.34% jump. Gross Profit Margin for this corporation currently stands at 0.31% with Operating Profit Margin at 0.01%, Pretax Profit Margin comes in at -0.01%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.01 and Total Capital is 0.0. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.32.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.52 points at the first support level, and at 6.30 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.87, and for the 2nd resistance point, it is at 6.99.
Ratios To Look Out For
It is important to note that LifeStance Health Group Inc [NASDAQ:LFST] has a current ratio of 1.58. In addition, the Quick Ratio stands at 1.58 and the Cash Ratio stands at 0.89. Considering the valuation of this stock, the price to sales ratio is 1.92, the price to book ratio is 1.76.
Transactions by insiders
Recent insider trading involved Miller Lisa K, that happened on Nov 21 ’25 when 57240.0 shares were sold. Officer, Miller Lisa K completed a deal on Nov 21 ’25 to buy 57240.0 shares. Meanwhile, Member of 10% Group Silversmith Partners I GP, LLC sold 3.59 million shares on Aug 18 ’25.
